3rd Quarter - Report

GILBERT'S LLP for MYLAN LABORATORIES INC

Firm
Client
Income
$90,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Consumer Issues/Safety/Products CSP

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES

Pharmacy PHA

Reform to legislation and regulations affecting pharmaceutical drug approval and marketing

LobbyistCovered position, as disclosed
NAWEL BAILEY —
TIM GILBERT —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.